Floatz logo

Milvexian

Healthy Volunteers

Bristol-Myers SquibbSmall moleculePhase 1Dormant
CC
44/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
81/ 100

Competitive context

65 Active assets in the Healthy Volunteers cohort.

Asset / SponsorPhaseRating
Semaglutide
Novo Nordisk A/S
Phase 4BB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
National Institute of Mental Health (NIMH)
Phase 4BB
DULAGLUTIDE
Novo Nordisk A/S
Phase 4BB
Alpha-1-Proteinase Inhibitor
Baxalta now part of Shire
Phase 4BB
NORMAL HUMAN SERUM ALBUMIN
Baxalta now part of Shire
Phase 4BB

View all 50 →

Same molecule, other indications

Milvexian is also rated in:

Ischemic Stroke; Ischemic Attack, TransientDormant
B
Indicative ·
60 / 100
View asset →
transient ischemic attackDormant
B
Indicative ·
57 / 100
View asset →
ischemic strokeDormant
CCC
Indicative ·
51 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →